Overview Quote
Stock Activity
| Day Low - High | 15.11 - 15.81 |
| 52wk Low - High | 3.57 - 15.81 |
| Previous Close | 14.93 |
| Avg. Volume | 99,484 |
| Industry | MED-OUTP/HM CRE |
| Market Cap | 166.27 M |
| Div - Yield | 0.00 - 0.00 |
| Beta | 0.17 |
| PE (Forward) | 17.27 |
| Current Year Est. | 0.89 |
| Quarterly Earnings ESP |
0.00% |
Premium research
Zacks Rank
|
1 |
Zacks Recommendation
|
Outperform |
Zacks Industry Rank
|
201 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Company Description
ADDUS HOMECARE is a comprehensive provider of a broad range of social and medical services in the home. The company's services include personal care and assistance with activities of daily living, skilled nursing and rehabilitative therapies, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, the Veterans Health Administration, commercial insurers and private individuals. Addus operates its business through two divisions, home & community services and home health services. The home & community services are social, or non-medical, in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living whereas the home health services are medical in nature and include physical, occupational and speech therapy, as well as skilled nursing.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 0.20 | 0.22 | 0.89 | 0.96 |
| Number of Estimates | 2 | 2 | 2 | 2 |
| Low Estimate | 0.19 | 0.21 | 0.88 | 0.94 |
| High Estimate | 0.20 | 0.24 | 0.90 | NA |
| Year Ago EPS | 0.14 | 0.19 | 0.86 | 0.89 |
| EPS Growth | 39.29% | 18.42% | 3.49% | 7.30% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| ADDUS HOMECARE | ADUS | 15.37 | ![]() |
![]() |
| HEALTHSOUTH CP | HLS | 30.36 | ![]() |
![]() |
| AMSURG CORP | AMSG | 36.38 | ![]() |
![]() |
| BRAIN RESOURCE | BRRZY | 0.00 | ![]() |
![]() |
| CHINA CORD BLD | CO | 2.82 | ![]() |
![]() |
| DAVITA INC | DVA | 128.14 | ![]() |
![]() |
| LHC GROUP LLC | LHCG | 22.56 | ![]() |
![]() |
| QUEST DIAGNOSTC | DGX | 60.69 | ![]() |
![]() |
| RADNET INC | RDNT | 2.54 | ![]() |
![]() |
| UNIVTY GEN HLTH | UGHS | 0.58 | ![]() |
![]() |
Sector:Medical>> Industry:MED-OUTP/HM CRE
Zacks Commentary
Weak 1Q Earnings for Gentiva
May 09, 2013
DaVita Reports Strong 1Q Earnings
May 08, 2013
Amedysis Reports 1Q Prelim Earnings
Apr 26, 2013
Coventry Upgraded to Strong Buy
Apr 11, 2013
DaVita Hit 52-Week High
Apr 03, 2013
Gentiva Downgraded to Strong Sell
Mar 25, 2013
Gentiva's 2013 Guidance Disappoints
Mar 21, 2013
Zacks Rank #1 Addition for Monday
Mar 18, 2013
Financials
| EPS TTM | 0.86 |
| Sales | 244 |
| Net Income | 20 |
| Price/Earnings | 17.87 |
| Price/Book | 1.76 |
| Price/Cash Flow | 13.81 |
| Price/Sales | 0.62 |
News
2 Stocks Spiking on Unusual Volume - TheStreet.com
May 6, 2013
Addus HomeCare Corp.Corporate Event Announcement Notice - Wall Street Horizon
May 3, 2013
Addus HomeCare Corp.Corporate Event Announcement Notice - Wall Street Horizon
May 2, 2013
Addus HomeCare Reports First Quarter 2013 Results - Pr Newswire
May 2, 2013
Addus HomeCare to Release 1Q 2013 Earnings - Close-Up Media
May 1, 2013
Addus HomeCare Corp.Corporate Event Announcement Notice - Wall Street Horizon
Apr 27, 2013
Addus HomeCare Corp.Corporate Event Announcement Notice - Wall Street Horizon
Apr 26, 2013
Addus HomeCare Announces First Quarter 2013 Earnings Release and Conference Call - Pr Newswire
Apr 25, 2013
Broker Recommendations
| Current ABR | 2.00 |
| ABR (Last Week) | 2.00 |
| # of recs in ABR | 2 |
| Average Target Price | 13.50 |
| Industry Rank by ABR | 201 out of 265 |
| Rank in Industry | 1 out of 16 |

